Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Robert Davis
Age : 53
Public asset : 19,778,241 USD
Country of residence : Unknown
Linked companies : Merck & Co., Inc. - Duke Energy Corporation

Biography of Robert Davis 
Mr. Robert M. Davis is an Independent Director at Duke Energy Corp., a President at Merck & Co., Inc. and a Chairman at Gambro AB. He is on the Board of Directors at Duke Energy Corp., AdvaMedDx, Project HOPE-The-People-To-People HealthFoundation, Inc. and Rush University Medical Center. Mr. Davis was previously employed as a Chief Financial Officer & Vice President by Baxter Healthcare Corp., a VP & President-Medical Products Business by Baxter International, Inc., and a Director-Corporate Financial Planning by Eli Lilly & Co. He also served on the board at C. R. Bard, Inc. (New Jersey). He received his undergraduate degree from Miami University, a graduate degree from Northwestern University School of Law and an MBA from Kellogg School of Management.


Current positions of Robert Davis 
Holdings of Robert Davis 
Robert Davis : Personal Network 
Most Read News 
11/23ELON MUSK : Tesla's Musk exercises more options, sells shares worth $1.05 billion
RE
12/05MUKESH AMBANI : Indian salesmen threaten supply disruptions in protest against Reliance
RE
11/30JACK DORSEY : Jack Dorsey chases crypto, fintech dream post Twitter
RE
11/24JAMIE DIMON : Jamie Dimon jokes that JPMorgan will outlast China's Communist Party
RE
12/01JACK DORSEY : Dorsey-led Square rebrands to Block in nod to blockchain
RE
12/03CATHIE WOOD : Cathie Wood's ARK Innovation fund hits 13-month low in tech selloff
RE
11/26ELON MUSK : Tesla decides against state aid for German battery plant as Musk opposes subsidies
RE
12/02ELON MUSK : Musk exercises more options, sells Tesla shares worth $1.01 billion
RE
11/23ERIK NORDSTROM : Nordstrom warns of supply shortages as holiday season approaches, shares plunge
RE
12/02TILMAN FERTITTA : FAST Acquisition refuses to terminate SPAC merger with Fertitta Entertainment
RE
More news


© 2021 People and Ownership :   
Robert Davis : Connections 


Latest news about Robert Davis 
10/28Merck sees up to $7 billion in sales of COVID-19 drug through end of 2022
RE
10/28Merck Raises 2021 Guidance as Drug Demand Firms With Third-Quarter Results Beating Estimates
MT
10/28Merck sees up to $7 billion in sales of COVID-19 drug through end of 2022
RE
10/11MERCK : Submits FDA Application for Emergency Use Authorization of COVID-19 Drug Molnupiravir
MT
10/04Merck pill seen as 'huge advance,' raises hope of preventing COVID-19 deaths
RE
10/01Merck pill seen as 'huge advance,' raises hope of preventing COVID-19 deaths
RE
09/13Merck sees potential U.S. authorization for COVID-19 antiviral before year-end
RE
More news